Schayek H, Haugk K, Sun S, True L, Plymate S, Werner H. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. Clin Cancer Res. 2009;15:1558-65 pubmed publisher

Wu J, Odman A, Higgins L, Haugk K, Vessella R, Ludwig D, et al. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. Clin Cancer Res. 2005;11:3065-74 pubmed

O'Neill A, Shah N, Zitomersky N, Ladanyi M, Shukla N, Uren A, et al. Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature. Sarcoma. 2013;2013:450478 pubmed publisher

Wang J, Ohara N, Wang Z, Chen W, Morikawa A, Sasaki H, et al. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum Reprod. 2006;21:1869-77 pubmed

Warnken M, Reitzenstein U, Sommer A, Fuhrmann M, Mayer P, Enzmann H, et al. Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:511-24 pubmed publisher

Plymate S, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, et al. An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer. Clin Cancer Res. 2007;13:6429-39 pubmed